|Articles|September 1, 2004

October 2004 Supplement Advertising Opportunities

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective

ByPartha Anbil,Anamika Krishanpal, PhD

September 2nd 2026

Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal

ByAndy Studna, Senior Editor

September 2nd 2026

Introducing The Human Side of Clinical Trials

ByBrian S. McGowan, PhD, FACEHP

September 2nd 2026

ACT Brief: RBQM Financial Value Quantification, Trial Budget Cost Visibility Gap, and GSK mRNA Flu Vaccine Phase III

ByAndy Studna, Senior Editor

September 2nd 2026

Why Quantifying the Financial Value of RBQM Has Been So Hard—and What This Study Did Differently

ByAbigail Dirks, MS,Sylviane de Viron,Andy Studna, Senior Editor

September 1st 2026

October 2004 Supplement Advertising Opportunities

Related Content

AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective

Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal

Introducing The Human Side of Clinical Trials

ACT Brief: RBQM Financial Value Quantification, Trial Budget Cost Visibility Gap, and GSK mRNA Flu Vaccine Phase III

Why Quantifying the Financial Value of RBQM Has Been So Hard—and What This Study Did Differently

Trending on Applied Clinical Trials Online

Agentic AI and the Administrative Backbone of Clinical Trials: Why the Operating Model Has to Change First

Introducing The Human Side of Clinical Trials

Why Quantifying the Financial Value of RBQM Has Been So Hard—and What This Study Did Differently

From Perspective to Action: Addressing the Real Cost Pressures in Clinical Trial Budgeting

Workforce Compression in AI-Driven Clinical Trial Operations